4,605 Shares in The Clorox Company (NYSE:CLX) Purchased by Navellier & Associates Inc.

Key Points

• Navellier & Associates Inc. has acquired 4,605 shares of The Clorox Company, valued at approximately $637,000, marking a new investment position in the first quarter.
• Clorox reported earnings per share (EPS) of $1.45 for the latest quarter, missing analysts' expectations of $1.57 by $0.12, with revenue also falling short at $1.67 billion.
• Over 78.53% of Clorox's stock is currently owned by institutional investors, with several companies, including American Century Companies and Sei Investments, increasing their stakes in the fourth quarter.

Navellier & Associates Inc. purchased a new position in The Clorox Company (NYSE:CLX - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,605 shares of the company's stock, valued at approximately $637,000.

Several other institutional investors also recently modified their holdings of CLX. American Century Companies Inc. increased its stake in shares of Clorox by 17.9% in the 4th quarter. American Century Companies Inc. now owns 76,400 shares of the company's stock worth $12,408,000 after acquiring an additional 11,606 shares in the last quarter. Sei Investments Co. increased its stake in Clorox by 28.6% during the 4th quarter. Sei Investments Co. now owns 98,794 shares of the company's stock valued at $16,045,000 after purchasing an additional 21,970 shares in the last quarter. Congress Wealth Management LLC DE increased its stake in Clorox by 26.9% during the 4th quarter. Congress Wealth Management LLC DE now owns 2,952 shares of the company's stock valued at $479,000 after purchasing an additional 626 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Clorox by 5.5% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 229,291 shares of the company's stock valued at $37,349,000 after purchasing an additional 11,953 shares in the last quarter. Finally, Elo Mutual Pension Insurance Co increased its stake in Clorox by 21.4% during the 4th quarter. Elo Mutual Pension Insurance Co now owns 13,396 shares of the company's stock valued at $2,176,000 after purchasing an additional 2,365 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

CLX opened at $130.80 on Friday. The company has a current ratio of 0.74, a quick ratio of 0.44 and a debt-to-equity ratio of 13.07. The company has a market cap of $16.12 billion, a price-to-earnings ratio of 23.48, a PEG ratio of 3.46 and a beta of 0.51. The company's 50 day moving average is $126.77 and its 200 day moving average is $140.29. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business's quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.71 EPS. On average, equities research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Insider Activity

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company's stock in a transaction that occurred on Wednesday, May 7th. The shares were bought at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the acquisition, the director owned 4,000 shares in the company, valued at $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on CLX shares. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research note on Friday. Barclays reduced their price objective on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research note on Tuesday, July 15th. Jefferies Financial Group reduced their price objective on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Wells Fargo & Company reduced their price objective on shares of Clorox from $142.00 to $135.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 9th. Finally, Morgan Stanley reduced their price objective on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, Clorox presently has a consensus rating of "Hold" and an average price target of $144.83.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.